Evidence map›Paper›PMID 35505605›Full record

ArticleEuropean journal of ophthalmology2023

"Vitreous Hemorrhage and Long-Lasting Priapism After COVID-19 m-RNA Based Vaccine: A Case Report".

Barbara Casarini, Francesco Bruni, Pierangela Rubino, Paolo Mora

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Barbara CasariniOphthalmology Unit, University Hospital of Parma, Parma, Italy.ORCID 0000-0002-3892-7886
Francesco BruniOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Pierangela RubinoOphthalmology Unit, University Hospital of Parma, Parma, Italy.
Paolo MoraOphthalmology Unit, University Hospital of Parma, Parma, Italy.
University of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report a case of possible multi-district thromboembolic event involving the eye of a patient with several cardiovascular risk factors, following a second inoculation of SARS-CoV-2 m-RNA based vaccine. CASE-REPORT: A 60-year-old man presented with blurred vision in the left eye lasting 1 month but started within 24 hours from the 2

conclusionsDue to the several predisposing factors such as diabetes, aspirin assumption, history of blood dyscrasia and infectious retinitis, the relationship between the acute intraocular bleeding and the BNT162b2 inoculation remains difficult to ascertain in this patient. However, the occurrence of lasting priapism and vitreous hemorrhage within 24 h from the vaccination is a critical event which deserves to be mentioned.

Indexed as

COVID-19Diabetes Mellitus, Type 2PriapismBNT162 VaccineHumansMaleMiddle AgedRetinal HemorrhageSARS-CoV-2Vitreous HemorrhageBNT162 VaccineBNT162b2 vaccineCOVID-19 thrombosispriapismSars-CoV-2 vaccineVascular anomaly

Identifiers

PMID35505605
PMCPMC9080970
OpenAlexW4225394247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.